OrbiMed’s Intuitive Surgical ISRG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $62.8M | Sell |
157,900
-50,800
| -24% | -$22.2M | 1.16% | 28 |
|
|
2026
Q1 | $96.2M | Sell |
208,700
-54,700
| -21% | -$27.7M | 1.91% | 15 |
|
|
2025
Q4 | $149M | Sell |
263,400
-23,800
| -8% | -$12.7M | 3.04% | 7 |
|
|
2025
Q3 | $128M | Sell |
287,200
-3,800
| -1% | -$1.82M | 3.02% | 9 |
|
|
2025
Q2 | $158M | Hold |
291,000
| – | – | 3.95% | 6 |
|
|
2025
Q1 | $144M | Sell |
291,000
-110,700
| -28% | -$61.2M | 3.44% | 6 |
|
|
2024
Q4 | $210M | Sell |
401,700
-32,100
| -7% | -$16.7M | 4.31% | 5 |
|
|
2024
Q3 | $213M | Sell |
433,800
-59,300
| -12% | -$27.6M | 3.87% | 5 |
|
|
2024
Q2 | $219M | Hold |
493,100
| – | – | 4.33% | 5 |
|
|
2024
Q1 | $197M | Sell |
493,100
-5,900
| -1% | -$2.23M | 3.6% | 5 |
|
|
2023
Q4 | $168M | Hold |
499,000
| – | – | 3.36% | 5 |
|
|
2023
Q3 | $146M | Sell |
499,000
-121,500
| -20% | -$37.9M | 3.1% | 4 |
|
|
2023
Q2 | $212M | Hold |
620,500
| – | – | 3.84% | 2 |
|
|
2023
Q1 | $159M | Hold |
620,500
| – | – | 3.11% | 6 |
|
|
2022
Q4 | $165M | Buy |
620,500
+47,800
| +8% | +$11.7M | 3.15% | 7 |
|
|
2022
Q3 | $107M | Buy |
572,700
+55,500
| +11% | +$11.9M | 1.99% | 13 |
|
|
2022
Q2 | $104M | Sell |
517,200
-17,000
| -3% | -$3.99M | 1.88% | 18 |
|
|
2022
Q1 | $161M | Buy |
534,200
+160,400
| +43% | +$46.9M | 2.61% | 8 |
|
|
2021
Q4 | $134M | Sell |
373,800
-45,000
| -11% | -$15.5M | 1.73% | 17 |
|
|
2021
Q3 | $139M | Hold |
418,800
| – | – | 1.53% | 20 |
|
|
2021
Q2 | $128M | Hold |
418,800
| – | – | 1.3% | 22 |
|
|
2021
Q1 | $103M | Buy |
418,800
+80,400
| +24% | +$20.2M | 0.96% | 31 |
|
|
2020
Q4 | $92.3M | Hold |
338,400
| – | – | 0.81% | 39 |
|
|
2020
Q3 | $80M | Hold |
338,400
| – | – | 1.01% | 28 |
|
|
2020
Q2 | $64.3M | Sell |
338,400
-168,900
| -33% | -$30.3M | 0.9% | 33 |
|
|
2020
Q1 | $83.7M | Buy |
507,300
+3,900
| +0.8% | +$714K | 1.41% | 27 |
|
|
2019
Q4 | $99.2M | Sell |
503,400
-113,400
| -18% | -$21.2M | 1.42% | 24 |
|
|
2019
Q3 | $111M | Sell |
616,800
-14,100
| -2% | -$2.44M | 2.11% | 12 |
|
|
2019
Q2 | $110M | Hold |
630,900
| – | – | 1.71% | 15 |
|
|
2019
Q1 | $120M | Buy |
630,900
+119,400
| +23% | +$21.2M | 1.86% | 14 |
|
|
2018
Q4 | $81.7M | Buy |
511,500
+234,900
| +85% | +$39.8M | 1.51% | 18 |
|
|
2018
Q3 | $52.9M | Sell |
276,600
-54,900
| -17% | -$9.75M | 0.64% | 48 |
|
|
2018
Q2 | $52.9M | Buy |
331,500
+25,500
| +8% | +$3.89M | 0.63% | 47 |
|
|
2018
Q1 | $42.1M | Sell |
306,000
-154,800
| -34% | -$21.6M | 0.52% | 57 |
|
|
2017
Q4 | $56.1M | Sell |
460,800
-46,800
| -9% | -$5.86M | 0.71% | 42 |
|
|
2017
Q3 | $59M | Buy |
507,600
+73,800
| +17% | +$8.04M | 0.56% | 52 |
|
|
2017
Q2 | $45.1M | Sell |
433,800
-19,800
| -4% | -$1.9M | 0.47% | 58 |
|
|
2017
Q1 | $38.6M | Sell |
453,600
-855,900
| -65% | -$67.6M | 0.44% | 59 |
|
|
2016
Q4 | $92.3M | Sell |
1,309,500
-380,700
| -23% | -$28M | 1.18% | 29 |
|
|
2016
Q3 | $136M | Sell |
1,690,200
-990,000
| -37% | -$75.8M | 1.55% | 23 |
|
|
2016
Q2 | $197M | Buy |
2,680,200
+189,000
| +8% | +$13.3M | 2.06% | 13 |
|
|
2016
Q1 | $166M | Buy |
2,491,200
+340,200
| +16% | +$21.1M | 1.75% | 17 |
|
|
2015
Q4 | $131M | Hold |
2,151,000
| – | – | 1.18% | 29 |
|
|
2015
Q3 | $110M | Sell |
2,151,000
-560,700
| -21% | -$31.8M | 1.11% | 31 |
|
|
2015
Q2 | $146M | Sell |
2,711,700
-975,600
| -26% | -$54.6M | 1.22% | 27 |
|
|
2015
Q1 | $207M | Sell |
3,687,300
-272,700
| -7% | -$15.4M | 1.77% | 22 |
|
|
2014
Q4 | $233M | Buy |
3,960,000
+482,400
| +14% | +$26.9M | 2.22% | 12 |
|
|
2014
Q3 | $178M | Sell |
3,477,600
-42,300
| -1% | -$2.1M | 1.86% | 17 |
|
|
2014
Q2 | $161M | Buy |
3,519,900
+493,200
| +16% | +$21.8M | 1.89% | 22 |
|
|
2014
Q1 | $147M | Buy |
3,026,700
+2,356,200
| +351% | +$111M | 1.81% | 21 |
|
|
2013
Q4 | $28.6M | Buy |
+670,500
| New | +$28.2M | 0.42% | 51 |
|
Other funds holding ISRG
OrbiMed's ISRG Position: Q2 2026 in Review
OrbiMed reduced its Intuitive Surgical (ISRG) stake by 24% in Q2 2026, selling an estimated $22.2M and leaving 157,900 shares worth $62.8M. The position accounts for 1.16% of the portfolio, ranked #28.
OrbiMed first reported a position in ISRG in Q4 2013 and has held it in 51 quarters since. The position peaked at $233M in Q4 2014. 2,246 funds tracked by Wall St. Rank hold ISRG as of Q2 2026.
- OrbiMed held 157,900 shares of Intuitive Surgical worth $62.8M as of Q2 2026.
- OrbiMed sold 50,800 Intuitive Surgical shares in Q2 2026, an estimated $22.2M.
- Intuitive Surgical made up 1.16% of OrbiMed's portfolio in Q2 2026, its #28 holding.
- OrbiMed first reported a position in Intuitive Surgical in Q4 2013 and has held it in 51 quarters since.
- OrbiMed's Intuitive Surgical position peaked at $233M in Q4 2014.
- 2,246 funds tracked by Wall St. Rank held Intuitive Surgical as of Q2 2026.
Based on OrbiMed's 13F filing for Q2 2026, filed 14 Aug 2026.